| abstract |
The use of gaseous oxygen for the production of a therapeutic gas for inhalation by a patient who has been identified as a person with a mitochondrial disorder or a coenzyme Q10 deficiency, for the treatment of mitochondrial disorders or Q10 deficiencies is disclosed. n For the first time a non-invasive method is disclosed, upon what the body's own level of Q10 can be raised significantly without further interventions. |